There is a great article in the Bismarck Tribune about the expansion of methadone services in Fargo, North Dakota. Fargo, like most other areas of the country, was impacted in recent years by numerous opioid-related overdose deaths.
The article reports that Cass County had 31 overdose deaths in 2016, but that number was reduced to 15 in 2017, due in part to the increased availability of naloxone (the medication that reverses opioid overdose).
While local ambulance calls have decreased in relation to opioid overdoses, the problem of opioid addiction remains a widespread and primary concern in the community.
The Tribune story reveals that more local residents are now enrolled in opioid treatment and are receiving the life-saving medication, methadone. Treatment that combines medication-assistance and counseling is the industry standard in quality care for those addicted to opioids.
The new Fargo-based clinic is reported to have 164 active patients currently enrolled in the methadone program. The clinic director, Mark Schaefer, is quoted as saying that while enrollment has been rapid, there remain many people in the local area with untreated opioid addiction.
The availability of treatment is making a difference. And medications like methadone, buprenorphine, and naloxone are providing a much needed solution to America’s opioid crisis.
The nation’s opioid epidemic has reached fever pitch and is now being spotlighted by all levels of local and national media. This is obviously good news.
At the center of this discussion is what can be done to reduce opioid fatalities, and to provide addicted people a real opportunity to regain control over their lives. This discussion inevitably leads to examining the benefit of medication-assisted treatment.
Methadone and buprenorphine are the two leading alternatives for helping patients deal with the perpetual withdrawal sickness that comes from a physiological dependency on opioids. Naloxone is a medication used to reverse opioid overdose.
In recent congressional testimony to members of Congress, Scott Gottlieb (Commissioner of the FDA) specifically heralded the life-saving benefits of methadone and similar medications.
His testimony included comments on the wealth of information behind the effectiveness of medication-assisted treatment. It is vitally important that legislative decision-makers obtain a clear understanding about what works and what does not in regard to coping successfully with this opioid crisis.
Time is of the essence because the present overdose fatality rate in the United States is over 64,000 per year. This number is beyond alarming. Here is an article that points to a possible positive shift in communities’ openness to having local opioid treatment nearby. Hopefully, this becomes a trend.
The U.S. House of Representatives just passed a sweeping reform, called the 21st Century Cures Act, that will infuse $1 billion in new funding earmarked for opioid treatment and prevention services.
It has taken several years of alarming statistics on the national opioid epidemic, but Congress has responded. This USA Today article provides an overview of the numbers. In addition to the $1 billion for opioid services will be another $4.8 billion for cutting-edge research around treating Alzheimers, cancer, traumatic brain injury, and other medical issues.
The bill received enormous bipartisan support and passed 392-to-26. In 2016, death by drug overdose surpassed death by car crashes and gun fatalities. The public outcry for government intervention has been steady. With so many families having been affected by addiction issues, the new funding allowance should open doors for opioid treatment particularly in rural areas where opioid services have been severely lacking.
Methadone remains the #1 medication-assisted treatment option. Buprenorphine medications are; however, making a big impact in the treatment field with a wide variety of buprenorphine-based formulations coming to market. In addition to the familiar suboxone film, are probuphine (a buprenorphine implant), subutex (an uncoated buprenorphine tablet), and bunavail.
Posted in Addiction Treatment, Buprenorphine, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Naloxone, Naltrexone, Opiate Treatment, Suboxone
Tagged drug legislation, drug treatment funding, opioid treatment
It was announced late last month that CVS Drugstores intends to expand their provision of non-prescription naloxone into 12 additional U.S. States. Currently, they provide naloxone over-the-counter in Rhode Island and Massachusetts, but will begin offering the life-saving medication in California, Minnesota, Mississippi, Arkansas, Montana, New Jersey, North Dakota, Pennsylvania, Tennessee, Utah, South Carolina, and Wisconsin.
Naloxone has gained attention in recent years due to its ability to reverse opioid overdoses. Over 44,000 people have died annually in the United States from drug overdose with a majority of those stemming from heroin or prescription pain medication. Naloxone has been successfully utilized in emergency rooms and on site in communities around the country reversing opioid overdose and saving thousands of lives.
It is critically important to recognize that people who have suffered with addiction are sometimes close to a lasting recovery. There is a popular expression used lately that is somewhat stark though true and thought-provoking. The expression goes “You can’t recover if you’re dead.” While this may sound off-putting to some, it reminds us that people stuck in years of painful addiction can, and do, change. We would much rather have naloxone readily available to save a life and to provide a son, daughter, or friend the opportunity to change direction.
An addicted individual could be much closer to choosing a life of recovery than we might imagine. This happens on a daily basis. How, and when, someone recovers from addiction is hard to predict. All we can do is to offer them an open door to a new and better life.
More Articles on Naloxone
Evzio is an FDA-approved emergency treatment that counteracts the effects of opioid overdose. It is an “auto-injector” designed to contain a retractable needle and a 0.4 mg dose of naloxone. Naloxone is a powerful opioid antagonist that reverses the effects of overdose with heroin or other opiates. Naloxone has been used throughout the country in the past few years and literally saved hundreds of lives.
Kaleo Pharma is the manufacturer of Evzio. The company specializes in innovative solutions for serious and life threatening medical conditions. Kaleo Pharma is based out of Richmond, Virginia, USA.
As has been documented in national media, very potent forms of heroin have become available much of it laced with other opiate derivatives like fentanyl. These combinations have proven lethal in a large number of cases often with younger people being the victims of overdose due to not understanding the extreme potency of the drugs being sold.
Products like Evzio in the hands of family and local emergency response teams can yield life saving interventions within minutes.
When addicted people survive a near fatal overdose, this often acts as a necessary catalyst to enter treatment and to step onto the path of personal recovery. Overdose survivors sometimes reflect on what has happened to them and may realize the pain that their death would have caused their children, friends, and family. The vast majority of overdoses are accidental and are nearly always preventable.
It is important to remember that addiction is an illness and that addicted people can recover, and can go on to live much improved lives when they are ready to change. Evzio will most likely save many people and give them that opportunity to live a life of real recovery.
Posted in Evzio, Heroin, Heroin Overdose, Methadone, Methadone Clinics, Methadone Overdose, Naloxone, Opiate Addiction, Recovery, Suboxone
Tagged Evzio, heroin overdose, naloxone, narcan